These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 12965874)

  • 1. Parity and the risk of Down's syndrome.
    Doria-Rose VP; Kim HS; Augustine ET; Edwards KL
    Am J Epidemiol; 2003 Sep; 158(6):503-8. PubMed ID: 12965874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Invited commentary: Parity and the risk of Down's syndrome--caution in interpretation.
    Chan A
    Am J Epidemiol; 2003 Sep; 158(6):509-11; discussion 512-3. PubMed ID: 12965875
    [No Abstract]   [Full Text] [Related]  

  • 3. Socioeconomic and state-level differences in prenatal diagnosis and live birth prevalence of Down's syndrome in the United States.
    Khoshnood B; Pryde P; Blondel B; Lee KS
    Rev Epidemiol Sante Publique; 2003 Dec; 51(6):617-27. PubMed ID: 14967994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A population-based evaluation of the impact of antenatal screening for Down's syndrome in France, 1981-2000.
    Khoshnood B; De Vigan C; Vodovar V; Goujard J; Goffinet F
    BJOG; 2004 May; 111(5):485-90. PubMed ID: 15104615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prenatal screening for Down's syndrome with use of maternal serum markers.
    Haddow JE; Palomaki GE; Knight GJ; Williams J; Pulkkinen A; Canick JA; Saller DN; Bowers GB
    N Engl J Med; 1992 Aug; 327(9):588-93. PubMed ID: 1379344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of a regional screening programme using maternal serum alpha fetoprotein (AFP) and human chorionic gonadotrophin (hCG) on the birth incidence of Down's syndrome in the west of Scotland.
    Crossley JA; Aitken DA; Berry E; Connor JM
    J Med Screen; 1994 Jul; 1(3):180-3. PubMed ID: 8790513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of Down's syndrome in a pregnant population in Finland.
    Marttala J; Yliniemi O; Gissler M; Nieminen P; Ryynanen M
    Acta Obstet Gynecol Scand; 2010 May; 89(5):715-7. PubMed ID: 20218932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Variations in the prevalence of Down's syndrome in the French population between 1978 and 2005].
    Rousseau T; Amar E; Ferdynus C; Thauvin-Robinet C; Gouyon JB; Sagot P
    J Gynecol Obstet Biol Reprod (Paris); 2010 Jun; 39(4):290-6. PubMed ID: 20430534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reducing the need for amniocentesis in women 35 years of age or older with serum markers for screening.
    Haddow JE; Palomaki GE; Knight GJ; Cunningham GC; Lustig LS; Boyd PA
    N Engl J Med; 1994 Apr; 330(16):1114-8. PubMed ID: 7510852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maternal smoking and Down syndrome: the confounding effect of maternal age.
    Chen CL; Gilbert TJ; Daling JR
    Am J Epidemiol; 1999 Mar; 149(5):442-6. PubMed ID: 10067903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening for fetal Down's syndrome in pregnancy by measuring maternal serum alpha-fetoprotein levels.
    DiMaio MS; Baumgarten A; Greenstein RM; Saal HM; Mahoney MJ
    N Engl J Med; 1987 Aug; 317(6):342-6. PubMed ID: 2439909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age-adjusted ultrasound risk assessment for fetal Down's syndrome during the second trimester: description of the method and analysis of 142 cases.
    Nyberg DA; Luthy DA; Resta RG; Nyberg BC; Williams MA
    Ultrasound Obstet Gynecol; 1998 Jul; 12(1):8-14. PubMed ID: 9697277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Down's syndrome: occurrence and outcome in the north of England, 1985-99.
    Bell R; Rankin J; Donaldson LJ;
    Paediatr Perinat Epidemiol; 2003 Jan; 17(1):33-9. PubMed ID: 12562470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antenatal screening for Down's syndrome.
    Wald NJ; Kennard A; Hackshaw A; McGuire A
    J Med Screen; 1997; 4(4):181-246. PubMed ID: 9494915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends in Down's syndrome prevalence in California, 1983-1988.
    Hahn JA; Shaw GM
    Paediatr Perinat Epidemiol; 1993 Oct; 7(4):450-60. PubMed ID: 8290384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in Down's syndrome live births and antenatal diagnoses in England and Wales from 1989 to 2008: analysis of data from the National Down Syndrome Cytogenetic Register.
    Morris JK; Alberman E
    BMJ; 2009 Oct; 339():b3794. PubMed ID: 19858532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reliability of statistics on Down's syndrome notifications.
    Huang T; Watt HC; Wald NJ; Morris JK; Mutton D; Alberman E
    J Med Screen; 1997; 4(2):95-7. PubMed ID: 9275267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strategies for antenatal detection of Down's syndrome.
    Wyllie JP; Madar RJ; Wright M; Burn J; Wren C
    Arch Dis Child Fetal Neonatal Ed; 1997 Jan; 76(1):F26-30. PubMed ID: 9059182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent trends in the prevalence and secondary prevention of Down's syndrome.
    Stone DH; Rosenberg K; Womersley J
    Paediatr Perinat Epidemiol; 1989 Jul; 3(3):278-83. PubMed ID: 2528127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Results of first year (1989) of a national register of Down's syndrome in England and Wales.
    Mutton DE; Alberman E; Ide R; Bobrow M
    BMJ; 1991 Nov; 303(6813):1295-7. PubMed ID: 1836152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.